Patent · US Active

Imidazopyridazine compounds and their use

US10611777B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Wei-Guo Su · Shanghai, CN
Guangxiu Dai · Shanghai, CN
Weihan Zhang · Shanghai, CN
Wei Deng · Shanghai, CN

Key dates

Filing date	Dec 20, 2018
Grant date	Apr 7, 2020
Priority date	—
Expiry date	Dec 20, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides novel imidazopyridazine compounds of formula (I) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting PI3K and potential use in treating a disease responsive to inhibition of PI3K, for example, an inflammatory disease, autoimmune disease or cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.